Physicochemical Properties
| Molecular Formula | C14H10N4O3 |
| Molecular Weight | 282.25 |
| Exact Mass | 282.075 |
| CAS # | 301675-24-1 |
| PubChem CID | 3572750 |
| Appearance | White to off-white solid powder |
| LogP | 3.63 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Heavy Atom Count | 21 |
| Complexity | 412 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | QPKROMNIEAEFQA-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C14H10N4O3/c19-13(9-4-3-5-10(8-9)18(20)21)17-14-15-11-6-1-2-7-12(11)16-14/h1-8H,(H2,15,16,17,19) |
| Chemical Name | N-(1H-benzimidazol-2-yl)-3-nitrobenzamide |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | IRAK4 4 μM (IC50) |
| ln Vitro | Compound 1, IRAK-4 protein kinase inhibitor 2, likewise inhibits IRAK-1, with an IC50 of less than 10 μM[1]. |
| References |
[1]. Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4. Bioorg Med Chem Lett. 2006 Jun 1;16(11):2842-5. |
Solubility Data
| Solubility (In Vitro) | DMSO: 10 mg/mL (35.43 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 1 mg/mL (3.54 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 10.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.5430 mL | 17.7148 mL | 35.4296 mL | |
| 5 mM | 0.7086 mL | 3.5430 mL | 7.0859 mL | |
| 10 mM | 0.3543 mL | 1.7715 mL | 3.5430 mL |